HK Rotates Toward Defensive Yields as AI and Biotech IPOs Command Premium BidsGlobal Report·1 day ago, 04:13 AM021420.00%01318-0.63%
HK Market Divergence: High-Yield Defense Surges as AI and Tech Pursue GrowthGlobal Report·2 days ago, 04:14 AM023560.00%021610.00%
The Fragmented Reality of Hong Kong Equities in 2026Global Report·Jul 31 at 04:21 AM021610.00%023560.00%
JBM Healthcare plans spin-off, Hong Kong listing of Chinese medicine unit JPJPUBT·Jul 17 at 07:09 AM021610.00%
From AI to Biotech: Inside the Fragmented Reality of Hong Kong's Stock MarketGlobal Report·Jul 17 at 04:12 AM021610.00%017790.00%
JBM (Healthcare) Sets August Virtual AGM With Dividend and Share Buyback Mandate on AgendaTip Ranks·Jul 15 at 08:09 AM021610.00%
Can China's JBM Healthcare Sustain Its 70% Dividend Payout?benzinga_article·Jun 30 at 11:01 AM021610.00%
JBM unit Po Chai Herbal buys Jacobson’s 24.9% Li Chung Shing Tong stake for HK$74.7 millionPUBT·Jun 29 at 07:22 AM026330.00%021610.00%
JBM (Healthcare) (SEHK:2161) Stock Faces Margin Slippage Question As Net Margin Eases To 24.1%Simplywall·Jun 23 at 06:07 AM021610.00%
JBM Healthcare FY26 profit attributable to shareholders rises 1.9% to HK$201.1 million; revenue increases 6.7% to HK$834.6 millionPUBT·Jun 22 at 09:26 AM021610.00%
